Reflect Scientific, Inc. (RSCF)
USD 0.04
(0.25%)
USD 0.04
(0.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 972.29 Thousand USD | 21.94% |
| 2022 | 797.35 Thousand USD | 27.68% |
| 2021 | 624.48 Thousand USD | 42.38% |
| 2020 | 438.6 Thousand USD | 73.46% |
| 2019 | 252.85 Thousand USD | 77.66% |
| 2018 | 142.32 Thousand USD | -8.39% |
| 2017 | 155.35 Thousand USD | -31.55% |
| 2016 | 226.96 Thousand USD | 9.96% |
| 2015 | 206.4 Thousand USD | -4.42% |
| 2014 | 215.95 Thousand USD | -31.02% |
| 2013 | 313.09 Thousand USD | -14.31% |
| 2012 | 365.39 Thousand USD | -7.03% |
| 2011 | 393 Thousand USD | 4.31% |
| 2010 | 376.75 Thousand USD | -36.32% |
| 2009 | 591.67 Thousand USD | -22.72% |
| 2008 | 765.58 Thousand USD | 5.17% |
| 2007 | 727.97 Thousand USD | 99.56% |
| 2006 | 364.79 Thousand USD | 19.34% |
| 2005 | 305.68 Thousand USD | 17.57% |
| 2004 | 260.01 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 950.91 Thousand USD | -2.2% |
| 2024 Q2 | 835.66 Thousand USD | -12.12% |
| 2023 FY | 972.29 Thousand USD | 21.94% |
| 2023 Q4 | 972.29 Thousand USD | 5.57% |
| 2023 Q3 | 920.95 Thousand USD | 5.0% |
| 2023 Q1 | 850.62 Thousand USD | 6.68% |
| 2023 Q2 | 877.08 Thousand USD | 3.11% |
| 2022 Q3 | 904.07 Thousand USD | 4.74% |
| 2022 Q1 | 695.6 Thousand USD | 11.39% |
| 2022 Q4 | 797.35 Thousand USD | -11.8% |
| 2022 FY | 797.35 Thousand USD | 27.68% |
| 2022 Q2 | 863.15 Thousand USD | 24.09% |
| 2021 Q2 | 524.08 Thousand USD | -8.81% |
| 2021 Q1 | 574.73 Thousand USD | 31.04% |
| 2021 FY | 624.48 Thousand USD | 42.38% |
| 2021 Q4 | 624.48 Thousand USD | 6.74% |
| 2021 Q3 | 585.05 Thousand USD | 11.63% |
| 2020 FY | 438.6 Thousand USD | 73.46% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q4 | 438.6 Thousand USD | 0.0% |
| 2019 Q4 | 252.85 Thousand USD | 38.38% |
| 2019 FY | 252.85 Thousand USD | 77.66% |
| 2019 Q3 | 182.72 Thousand USD | 12.38% |
| 2019 Q2 | 162.59 Thousand USD | 4.88% |
| 2019 Q1 | 155.03 Thousand USD | 8.93% |
| 2018 Q3 | 142.81 Thousand USD | -13.61% |
| 2018 Q4 | 142.32 Thousand USD | -0.34% |
| 2018 FY | 142.32 Thousand USD | -8.39% |
| 2018 Q1 | 149.21 Thousand USD | -3.95% |
| 2018 Q2 | 165.3 Thousand USD | 10.78% |
| 2017 FY | 155.35 Thousand USD | -31.55% |
| 2017 Q2 | 216.65 Thousand USD | -6.8% |
| 2017 Q1 | 232.45 Thousand USD | 2.42% |
| 2017 Q4 | 155.35 Thousand USD | -32.92% |
| 2017 Q3 | 231.6 Thousand USD | 6.9% |
| 2016 FY | 226.96 Thousand USD | 9.96% |
| 2016 Q4 | 226.96 Thousand USD | 14.98% |
| 2016 Q2 | 196.77 Thousand USD | -1.36% |
| 2016 Q1 | 199.49 Thousand USD | -3.35% |
| 2016 Q3 | 197.39 Thousand USD | 0.31% |
| 2015 Q4 | 206.4 Thousand USD | -14.35% |
| 2015 FY | 206.4 Thousand USD | -4.42% |
| 2015 Q3 | 240.97 Thousand USD | 0.33% |
| 2015 Q2 | 240.17 Thousand USD | 11.87% |
| 2015 Q1 | 214.69 Thousand USD | -0.58% |
| 2014 Q4 | 215.95 Thousand USD | -27.49% |
| 2014 Q3 | 297.83 Thousand USD | -1.13% |
| 2014 FY | 215.95 Thousand USD | -31.02% |
| 2014 Q2 | 301.24 Thousand USD | 2.32% |
| 2014 Q1 | 294.42 Thousand USD | -5.96% |
| 2013 FY | 313.09 Thousand USD | -14.31% |
| 2013 Q4 | 313.09 Thousand USD | -4.91% |
| 2013 Q3 | 329.26 Thousand USD | 1.07% |
| 2013 Q2 | 325.77 Thousand USD | -7.45% |
| 2013 Q1 | 351.98 Thousand USD | -3.67% |
| 2012 FY | 365.39 Thousand USD | -7.03% |
| 2012 Q2 | 370.87 Thousand USD | -9.43% |
| 2012 Q1 | 409.46 Thousand USD | 4.19% |
| 2012 Q3 | 378.89 Thousand USD | 2.16% |
| 2012 Q4 | 365.39 Thousand USD | -3.56% |
| 2011 Q1 | 375.39 Thousand USD | -0.36% |
| 2011 Q3 | 445.85 Thousand USD | 2.74% |
| 2011 Q2 | 433.95 Thousand USD | 15.6% |
| 2011 FY | 393 Thousand USD | 4.31% |
| 2011 Q4 | 393 Thousand USD | -11.85% |
| 2010 Q1 | 372.07 Thousand USD | -37.11% |
| 2010 Q4 | 376.75 Thousand USD | -5.12% |
| 2010 FY | 376.75 Thousand USD | -36.32% |
| 2010 Q3 | 397.07 Thousand USD | 5.74% |
| 2010 Q2 | 375.51 Thousand USD | 0.92% |
| 2009 Q3 | 591.91 Thousand USD | -24.93% |
| 2009 Q2 | 788.53 Thousand USD | 2.56% |
| 2009 Q1 | 768.87 Thousand USD | 0.43% |
| 2009 FY | 591.67 Thousand USD | -22.72% |
| 2009 Q4 | 591.67 Thousand USD | -0.04% |
| 2008 FY | 765.58 Thousand USD | 5.17% |
| 2008 Q3 | 1.64 Million USD | 28.09% |
| 2008 Q2 | 1.28 Million USD | 7.57% |
| 2008 Q1 | 1.19 Million USD | 64.13% |
| 2008 Q4 | 765.58 Thousand USD | -53.5% |
| 2007 Q2 | 598.98 Thousand USD | -19.03% |
| 2007 Q4 | 727.97 Thousand USD | -11.28% |
| 2007 FY | 727.97 Thousand USD | 99.56% |
| 2007 Q3 | 820.54 Thousand USD | 36.99% |
| 2007 Q1 | 739.72 Thousand USD | 102.78% |
| 2006 Q2 | 543.91 Thousand USD | 70.93% |
| 2006 Q3 | 377.1 Thousand USD | -30.67% |
| 2006 Q4 | 364.79 Thousand USD | -3.26% |
| 2006 Q1 | 318.2 Thousand USD | 4.1% |
| 2006 FY | 364.79 Thousand USD | 19.34% |
| 2005 FY | 305.68 Thousand USD | 17.57% |
| 2005 Q3 | 353.14 Thousand USD | 17.34% |
| 2005 Q1 | 269.11 Thousand USD | 0.0% |
| 2005 Q4 | 305.68 Thousand USD | -13.44% |
| 2005 Q2 | 300.95 Thousand USD | 11.83% |
| 2004 FY | 260.01 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -626.519% |
| Ansell Limited | 457.04 Million USD | 99.787% |
| Ansell Limited | 457.9 Million USD | 99.788% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | 97.756% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -3386.171% |
| Psykey, Inc. | 49.94 Thousand USD | -1846.922% |
| ConvaTec Group Plc | 395.54 Million USD | 99.754% |
| ConvaTec Group Plc | 396.1 Million USD | 99.755% |
| Encision Inc. | 1.4 Million USD | 30.666% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 10561.513% |
| LifePoint, Inc. | 2.3 Million USD | 57.897% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 59.538% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -120.475% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -958.197% |
| SmileDirectClub, Inc. | 49.87 Million USD | 98.051% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 99.724% |
| SheerVision, Inc. | 339.66 Thousand USD | -186.252% |
| United Health Products, Inc. | 33.59 Thousand USD | -2793.901% |
| Vasamed, Inc. | 449.02 Thousand USD | -116.533% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -11265.202% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -201.792% |